G36o36G
commented on
$iRobot (IRBT.US)$ $The Beauty Health (SKIN.US)$ $Ispire Technology (ISPR.US)$ $Blade Air Mobility (BLDE.US)$ $Ovid Therapeutics (OVID.US)$ $Macrogenics (MGNX.US)$ $Outset Medical (OM.US)$ $Oruka Therapeutics (ORKA.US)$ $Iovance Biotherapeutics (IOVA.US)$ $Dynavax Technologies (DVAX.US)$ $NN Inc (NNBR.US)$ $Richtech Robotics (RR.US)$ $Lifecore Biomedical (LFCR.US)$ $Opendoor Technologies (OPEN.US)$ $Tonix Pharmaceuticals (TNXP.US)$ $Pyxis Oncology (PYXS.US)$ $Kymera Therapeutics (KYMR.US)$ $Luminar Technologies (LAZR.US)$ $Kopin (KOPN.US)$ $Cidara Therapeutics (CDTX.US)$ $Vuzix (VUZI.US)$ $Tango Therapeutics (TNGX.US)$ $Solid Biosciences (SLDB.US)$ $Gevo Inc (GEVO.US)$ $aTyr Pharma (ATYR.US)$ $Xponential Fitness (XPOF.US)$
22
9
3
G36o36G
reacted to
G36o36G
commented on
$Incannex Healthcare (IXHL.US)$ Investors and community sources are actively speculating that results may be published as soon as July 20, 2025, but this has not been formally confirmed by the company.
6
7
G36o36G
commented on
Translated
1
6
G36o36G
commented on
$Ocean Power Technologies (OPTT.US)$ Something is ongoing.. but no news..
1
1
G36o36G
commented on
$Ryvyl (RVYL.US)$ shorties don't file offerings, CEOs do. CEO is the super mega ultra Shortie. Be careful for that guy might reverse split your investment next and continue diluting you into oblivion because hes "the boss".![]()
3
2
$Onconetix (ONCO.US)$
Analysis of Onconetix Merger News and Stock Price Movement
1. Merger Announcement Impact
Onconetix (ONCO.US) announced a reverse merger with Ocuvex Therapeutics on July 16, 2025, where Onconetix shareholders will retain 10% ownership in the combined entity, while Ocuvex investors will hold 90%252733. This significant dilution for existing shareholders led to a sharp 19% intraday decline on July 16, with the stock hitting an all-time low of $3.16 befo...
Analysis of Onconetix Merger News and Stock Price Movement
1. Merger Announcement Impact
Onconetix (ONCO.US) announced a reverse merger with Ocuvex Therapeutics on July 16, 2025, where Onconetix shareholders will retain 10% ownership in the combined entity, while Ocuvex investors will hold 90%252733. This significant dilution for existing shareholders led to a sharp 19% intraday decline on July 16, with the stock hitting an all-time low of $3.16 befo...
1
1
G36o36G
commented on
2
G36o36G
commented on
$Aptorum (APM.US)$ Hehehe Show me 3.54! Break them all fer me! Yes you’re Huckleberry! Hehehe
5
5
G36o36G :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)